According to a Sept. 29 news release, the four new areas of focus include disruptive technology empowering precision health, or D-TECH; health equity; infection, inflammation, immunity and immunotherapy, or I-4ward; and brain health and disease across the lifespan.
The senior vice dean for research in the Heersink School of Medicine, Tika Benveniste, PhD, thanked the faculty and the committees for their effort in establishing the research focus areas.
“I am excited that our new research focus areas provide a strong foundation for the future of scientific impact and growth here at UAB,” Dr. Benveniste said.
